There is a poor prognosis within the HF domain. The National HF Audit and NICE project that LVSD is the cause of HF in 50-70% of cases yet official QOF data shows it’s only coded in 1 out of 3 patients with HF.
The HF Plus tool closes that gap supporting practices by further interrogating the HF QOF domain, identifying, adding and enabling better management of appropriate patients.
In addition to the clinical benefits of this process improving patient care, practices will see an uplift in QOF income to be reinvested within the practice.
HF Plus is available as an individual service or in combination with our current QOF Enhancement tiers.
View our HF Plus Case Study to find out how the service is benefiting practices and patients.